PE20001557A1 - Nueva cepa lactobacillus que previene diarrea causada por bacterias patogenas - Google Patents

Nueva cepa lactobacillus que previene diarrea causada por bacterias patogenas

Info

Publication number
PE20001557A1
PE20001557A1 PE2000000213A PE0002132000A PE20001557A1 PE 20001557 A1 PE20001557 A1 PE 20001557A1 PE 2000000213 A PE2000000213 A PE 2000000213A PE 0002132000 A PE0002132000 A PE 0002132000A PE 20001557 A1 PE20001557 A1 PE 20001557A1
Authority
PE
Peru
Prior art keywords
pathogenic bacteria
milk
fermented
new strain
lactobacillus
Prior art date
Application number
PE2000000213A
Other languages
English (en)
Spanish (es)
Inventor
Jean-Richard Neeser
Alain Servin
Roberto Reniero
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of PE20001557A1 publication Critical patent/PE20001557A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
    • A23G9/00—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor
    • A23G9/32—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds
    • A23G9/36—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins
    • A23G9/363—Frozen sweets, e.g. ice confectionery, ice-cream; Mixtures therefor characterised by the composition containing organic or inorganic compounds containing microorganisms or enzymes; containing paramedical or dietetical agents, e.g. vitamins containing microorganisms, enzymes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/175—Rhamnosus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Confectionery (AREA)
  • Cereal-Derived Products (AREA)
PE2000000213A 1999-03-11 2000-03-10 Nueva cepa lactobacillus que previene diarrea causada por bacterias patogenas PE20001557A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99104922A EP1034787A1 (en) 1999-03-11 1999-03-11 Lactobacillus strains preventing diarrhea caused by pathogenic bacteria

Publications (1)

Publication Number Publication Date
PE20001557A1 true PE20001557A1 (es) 2001-02-01

Family

ID=8237746

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2000000213A PE20001557A1 (es) 1999-03-11 2000-03-10 Nueva cepa lactobacillus que previene diarrea causada por bacterias patogenas

Country Status (23)

Country Link
US (1) US6835376B1 (https=)
EP (2) EP1034787A1 (https=)
JP (1) JP2002537865A (https=)
CN (1) CN1350461A (https=)
AR (1) AR022912A1 (https=)
AU (1) AU779414B2 (https=)
BR (1) BR0008911A (https=)
CA (1) CA2364435A1 (https=)
CO (1) CO5241327A1 (https=)
CZ (1) CZ20013264A3 (https=)
HK (1) HK1042657A1 (https=)
HU (1) HUP0200205A3 (https=)
ID (1) ID30438A (https=)
IL (2) IL145079A0 (https=)
MY (1) MY125941A (https=)
NO (1) NO20014299L (https=)
NZ (1) NZ513806A (https=)
PE (1) PE20001557A1 (https=)
PL (1) PL355226A1 (https=)
RO (1) RO121701B1 (https=)
RU (2) RU2247569C2 (https=)
WO (1) WO2000053200A1 (https=)
ZA (2) ZA200107293B (https=)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7029702B2 (en) * 1998-07-07 2006-04-18 Ritter Natural Sciences Llc Method for increasing lactose tolerance in mammals exhibiting lactose intolerance
SE523771C2 (sv) * 1999-05-21 2004-05-18 Probi Ab Sportdryck innehållande mikronäringsämnen i kombination med levande laktobaciller
DE60119515T2 (de) * 2000-05-25 2007-05-24 Société des Produits Nestlé S.A. Probiotica für verwendung als haustierfutter
SE0003100D0 (sv) 2000-09-01 2000-09-01 Probi Ab New strains
SE0003576D0 (sv) * 2000-10-04 2000-10-04 Probi Ab New strain
KR100419132B1 (ko) * 2000-12-29 2004-02-18 조성근 위·장 점막 부착성과 증식성, 내산성, 내담즙성 및헬리코박터 파일로리, 대장균 0157:ｈ7에 대한 항균성이우수한 락토바실러스 파라카제이 서브스패시즈 파라카제이ｃｓｋ 01
SE0103695D0 (sv) 2001-11-07 2001-11-07 Thomas Boren A novel non-antibiotic strategy against OGIP infections based on a cereal product
WO2003080813A2 (en) 2002-03-21 2003-10-02 Bifodan A/S Lactobacillus strains
JP4308481B2 (ja) * 2002-06-18 2009-08-05 独立行政法人農業・食品産業技術総合研究機構 抗アレルギー剤
DK1565547T4 (da) 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
JP2004189672A (ja) * 2002-12-11 2004-07-08 Gen Corp:Kk 抗下痢症組成物
EP1759597B1 (en) * 2003-03-13 2009-01-21 Kirin Holdings Kabushiki Kaisha Probiotic composition
WO2004087891A1 (en) * 2003-04-02 2004-10-14 Axcan Pharma S.A. Lactobacillus fermentum strain and uses thereof
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MY143693A (en) 2004-03-24 2011-06-30 Nestec Sa Shelf stable product wih living micro-organisms
ITRM20040166A1 (it) * 2004-03-31 2004-06-30 Alberto Cresci Ceppi batterici lab con proprieta' probiotiche e composizioni che contengono gli stessi.
WO2006012536A2 (en) * 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
TW200637908A (en) * 2005-01-04 2006-11-01 Calpis Co Ltd Method for preparation of lactic acid bacterium having anti-allergic activity
AU2006233918B2 (en) 2005-04-13 2012-06-21 Nestec S.A. Infant formula with probiotics
US20060263311A1 (en) * 2005-05-19 2006-11-23 Scavone Timothy A Consumer noticeable improvement in wetness protection using solid antiperspirant compositions
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
WO2007040446A1 (en) * 2005-10-06 2007-04-12 Probi Ab Use of lactobacillus for treatment of autoimmune diseases
ES2381211T3 (es) 2006-02-15 2012-05-24 Nestec S.A. Uso del Bifidobacterium longum para prevenir y tratar inflamaciones
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
DE502007004849D1 (de) * 2007-02-02 2010-10-07 May Amadeus Alexander Produkt mit lebenden probiotischen Mikroorganismen
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
EP1974743A1 (en) 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
CN101273737B (zh) * 2007-03-28 2011-08-24 哈尔滨正方科技有限公司 一种在常温下保持高活菌数的发酵乳饮料的制备方法
PL2173196T3 (pl) * 2007-07-06 2011-06-30 Nutricia Nv Zastosowanie probiotyków i włókien w biegunce
US20090110663A1 (en) * 2007-10-24 2009-04-30 Halow George M Method for treatment of bowel disorders
EP2072052A1 (en) 2007-12-17 2009-06-24 Nestec S.A. Prevention of opportunistic infections in immune-compromised subjects
KR20100120169A (ko) 2008-01-24 2010-11-12 네스텍 소시에테아노님 영양 성분을 담고 있는 캡슐 및 이 캡슐로부터 영양액을 전달하는 방법
ES2658837T3 (es) 2008-03-14 2018-03-12 Nestec S.A. Mezcla simbiótica
EP2127661A1 (en) 2008-05-27 2009-12-02 Nestec S.A. Probiotics to improve gut microbiotica
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
EP2293802A4 (en) * 2008-06-25 2011-11-09 Ritter Pharmaceuticals Inc LACTOSE COMPOSITIONS HAVING REDUCED LACTOSE CONTENT
EP2147678A1 (en) 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
EP2166083B1 (en) * 2008-12-31 2010-12-22 Syngen biotech CO., LTD. Novel Lactobacillus paracasei subsp. paracasei SG96, a bacteriostatic composition containing the same and use thereof
US20100196341A1 (en) * 2009-02-05 2010-08-05 Syngen Biotech Co., Ltd. Novel Lactobacillus paracasei subsp. paracasei SG96, a Bacteriostatic Composition Containing the same and Use Thereof
EP2400839B1 (en) 2009-02-24 2016-09-07 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US10576110B2 (en) * 2009-05-11 2020-03-03 Societe Des Produits Nestle S.A. Lactobacillus johnsonii La1 NCC533 (CNCM I-1225) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2509429A1 (en) 2009-12-08 2012-10-17 Nestec S.A. Infant formula with probiotics and milk fat globule membrane components
EP3202406A1 (en) 2010-04-28 2017-08-09 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
DK2734049T3 (en) 2011-06-20 2018-07-30 Heinz Co Brands H J Llc PROBIOTIC COMPOSITIONS AND PROCEDURES
EP3351554B1 (en) 2012-06-18 2021-06-09 H.J. Heinz Company Brands LLC Gluten-related disorders
PL2994150T3 (pl) 2013-05-10 2019-09-30 H.J. Heinz Company Brands Llc Probiotyki i sposoby zastosowania
EP3940067A1 (en) 2014-12-05 2022-01-19 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016183532A1 (en) 2015-05-13 2016-11-17 Synlogic, Inc. Bacteria engineered to treat a disease or disorder
SG11201704543XA (en) 2014-12-05 2017-07-28 Synlogic Inc Bacteria engineered to treat diseases associated with hyperammonemia
US9688967B2 (en) 2014-12-05 2017-06-27 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
US20160206666A1 (en) 2014-12-22 2016-07-21 Synlogic, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tighten gut mucosal barrier
JP7095993B2 (ja) 2015-03-02 2022-07-05 シンロジック オペレーティング カンパニー インコーポレイテッド 消化管炎症低下および／または消化管粘膜バリア強化の利益を享受する疾患処置のために操作された細菌
ES2881384T3 (es) 2015-05-13 2021-11-29 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
WO2016200614A2 (en) 2015-06-10 2016-12-15 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
WO2016210373A2 (en) 2015-06-24 2016-12-29 Synlogic, Inc. Recombinant bacteria engineered for biosafety, pharmaceutical compositions, and methods of use thereof
WO2016210378A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Multi-layered control of gene expression in genetically engineered bacteria
WO2016210384A2 (en) 2015-06-25 2016-12-29 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
EP3328988A1 (en) 2015-07-31 2018-06-06 Synlogic, Inc. Bacteria engineered to treat disorders involving propionate catabolism
US11273184B2 (en) 2015-08-31 2022-03-15 Synlogic Operating Company, Inc. Bacteria engineered to treat disorders in which oxalate is detrimental
EP3368696A1 (en) 2015-10-30 2018-09-05 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017075485A1 (en) 2015-10-30 2017-05-04 Synlogic, Inc. Bacteria engineered to treat disorders in which trimethylamine (tma) is detrimental
US11685925B2 (en) 2015-10-30 2023-06-27 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
ES2925049T3 (es) 2015-11-16 2022-10-13 Synlogic Operating Co Inc Bacterias manipuladas para reducir la hiperfenilalaninemia
WO2017123418A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat metabolic diseases
WO2017123592A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to treat disorders associated with bile salts
EP3402498A1 (en) 2016-01-11 2018-11-21 Synlogic, Inc. Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells
WO2017123676A1 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof
WO2017123610A2 (en) 2016-01-11 2017-07-20 Synlogic, Inc. Bacteria engineered to detoxify deleterious molecules
EP3411051A2 (en) 2016-02-04 2018-12-12 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases that benefit from reduced gut inflammation and/or tightened gut mucosal barrier
WO2017136795A1 (en) 2016-02-04 2017-08-10 Synlogic, Inc. Bacteria engineered to treat diseases associated with tryptophan metabolism
WO2017139708A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat nonalcoholic steatohepatitis (nash)
WO2017139697A1 (en) 2016-02-10 2017-08-17 Synlogic, Inc. Bacteria engineered to treat diseases associated with hyperammonemia
BR112018071271B1 (pt) * 2016-05-11 2023-04-11 Chr. Hansen A/S Processo para a produção de um produto alimentício de armazenamento ambiente
BR112019013863A2 (pt) 2017-01-06 2020-03-03 Synlogic Operating Company, Inc. Micro-organismos programados para produzir moduladores imunes e terapêuticos anticâncer em células tumorais
US10941433B2 (en) 2017-06-15 2021-03-09 Iowa State University Research Foundation, Inc. Neurotransmitter transport in probiotics
CN111655841A (zh) 2017-06-21 2020-09-11 同生运营公司 用于治疗紊乱的细菌
JP2020527025A (ja) 2017-07-12 2020-09-03 シンロジック オペレーティング カンパニー インコーポレイテッド 腫瘍細胞において免疫モジュレーターおよび抗がん治療剤を産生するようにプログラムされた微生物
US20210130806A1 (en) 2017-11-03 2021-05-06 Synlogic Operating Company, Inc. Engineered bacteria expressing racemase for treating diseases associated with hyperammonemia
CN110960559B (zh) * 2018-09-30 2021-02-26 内蒙古伊利实业集团股份有限公司 用于抑制口腔病原菌的乳酸菌菌株的食品、口腔清洁以及医药组合物
US11274275B2 (en) 2018-09-30 2022-03-15 Inner Mongolia Yili Industrial Group Co., Ltd. Lactobacillus paracasei ET-22 and use thereof
KR20220003030A (ko) 2019-04-29 2022-01-07 신로직 오퍼레이팅 컴퍼니, 인코포레이티드 살아 있는 세포 계수 기술에 의한 유전적으로 조작된 미생물의 계수
US20230173066A1 (en) 2019-07-23 2023-06-08 Frieslandcampina Nederland B.V. Nutritional composition comprising milk fat and immunoglobulin
JP2022548785A (ja) 2019-09-24 2022-11-21 プロラクタ バイオサイエンス，インコーポレイテッド 炎症性疾患及び免疫疾患の治療のための組成物及び方法
MX2022007925A (es) 2019-12-24 2022-09-29 Univ Iowa State Res Found Inc Control de histamina para promover la salud y controlar la enterocolitis usando composiciones probioticas y/o enzimas, que degrada histamina.
CN113355252A (zh) * 2020-03-06 2021-09-07 南京卫岗乳业有限公司 一种副干酪乳杆菌及其应用
BR112022018571A2 (pt) 2020-03-20 2022-11-01 Synlogic Operating Co Inc Microrganismos manipulados para reduzir a hiperfenilalaninemia
KR20230088680A (ko) 2020-08-14 2023-06-20 프롤랙타 바이오사이언스, 인코포레이티드 박테리아 요법에 사용하기 위한 인간 모유 올리고당 조성물
EP4256039A2 (en) 2020-12-02 2023-10-11 Synlogic Operating Company, Inc. Engineered microorganisms
CN116847860A (zh) 2020-12-31 2023-10-03 同生运营公司 经工程化以减轻高苯丙氨酸血症的微生物
CA3204530A1 (en) 2021-01-12 2022-07-21 Gregory Mckenzie Synbiotic treatment regimens
CN112625983B (zh) * 2021-03-05 2021-05-28 山东中科嘉亿生物工程有限公司 一种对腹泻有治疗效果的干酪乳杆菌L.Casei21及其应用
CN112877260B (zh) * 2021-03-30 2022-08-09 江南大学 一株缓解泻剂结肠的副干酪乳杆菌及其应用
EP4323385A1 (en) 2021-04-13 2024-02-21 Synlogic Operating Company, Inc. Bacteria engineered to secrete active proteins
CN115671144A (zh) * 2021-07-26 2023-02-03 锦乔生物科技有限公司 使用乳酸菌菌株的培养物来抑制肠道病原菌生长和预防和/或治疗与肠道病原菌有关的疾病
WO2023044479A1 (en) 2021-09-17 2023-03-23 Synlogic Operating Company, Inc. Methods for reducing hyperphenylalaninemia
WO2023245168A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
WO2023245171A1 (en) 2022-06-17 2023-12-21 Synlogic Operating Company, Inc. Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof
CA3260270A1 (en) 2022-06-22 2023-12-28 Iowa State University Research Foundation, Inc. FIGHTING HISTAMINE TO PROMOTE HEALTH AND COMBAT ENTEROCOLITIS WITH PROBIOTIC COMPOUNDS
CA3260276A1 (en) 2022-06-23 2023-12-28 Michael James Genetically modified recombinant bacteria for treating diseases associated with methionine metabolism and associated methods of use
WO2024081768A1 (en) 2022-10-12 2024-04-18 Synlogic Operating Company, Inc. Bacteria engineered to produce active epidermal growth factor (egf) and their medical uses
EP4605522A1 (en) 2022-10-17 2025-08-27 Synlogic Operating Company, Inc. Recombinant bacteria expressing phenylalanine ammonia lyase, phenylalanine transporter and l- aminoacid deaminase for reducing hyperphenylalaninemia
WO2024129974A1 (en) 2022-12-14 2024-06-20 Synlogic Operating Company, Inc. Recombinant bacteria for use in the treatment of disorders in which oxalate is detrimental
WO2024130119A2 (en) 2022-12-16 2024-06-20 Prolacta Bioscience, Inc. Synbiotic compositions for short chain fatty acid production
EP4647439A1 (en) 2024-05-09 2025-11-12 Alma Mater Studiorum - Università di Bologna Non-pathogenic bacteria for delivery of ptd-fusion proteins

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
ATE161181T1 (de) * 1992-07-06 1998-01-15 Nestle Sa Lactobacillus acidophilus enthaltende antigastritis-mittel
NZ287420A (en) * 1994-05-26 1997-12-19 Bracco Spa Lactobacillus strains with enhanced gut adhesion
JP3004890B2 (ja) * 1995-03-28 2000-01-31 雪印乳業株式会社 病原体感染防御剤
US5837238A (en) * 1996-06-05 1998-11-17 Biogaia Biologics Ab Treatment of diarrhea
IT1284877B1 (it) * 1996-08-09 1998-05-22 Dicofarm Spa Trattamento delle diarree acute del bambino e prevenzione della sensibilizzazione allergica verso alimenti introdotti nella fase
IT1289984B1 (it) * 1997-02-27 1998-10-19 Proge Farm Srl Ceppi di lattobacilli utili nel trattamento di disfunzioni del sistema gastrointestinale
SE511524C2 (sv) * 1997-06-02 1999-10-11 Essum Ab Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
IL145080A0 (en) * 1999-03-11 2002-06-30 Nestle Sa Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses

Also Published As

Publication number Publication date
EP1162986A1 (en) 2001-12-19
WO2000053200A1 (en) 2000-09-14
BR0008911A (pt) 2002-01-15
HUP0200205A3 (en) 2002-06-28
CA2364435A1 (en) 2000-09-14
ZA200107290B (en) 2003-02-26
CN1350461A (zh) 2002-05-22
HK1042657A1 (zh) 2002-08-23
NZ513806A (en) 2003-08-29
RU2247569C2 (ru) 2005-03-10
PL355226A1 (en) 2004-04-05
HUP0200205A2 (hu) 2002-05-29
ID30438A (id) 2001-12-06
AU779414B2 (en) 2005-01-20
CZ20013264A3 (cs) 2002-01-16
RU2243779C2 (ru) 2005-01-10
MY125941A (en) 2006-09-29
NO20014299D0 (no) 2001-09-04
IL145079A (en) 2006-08-01
US6835376B1 (en) 2004-12-28
IL145079A0 (en) 2002-06-30
AR022912A1 (es) 2002-09-04
JP2002537865A (ja) 2002-11-12
NO20014299L (no) 2001-11-05
RO121701B1 (ro) 2008-02-28
ZA200107293B (en) 2003-02-26
CO5241327A1 (es) 2003-01-31
EP1034787A1 (en) 2000-09-13
AU3162700A (en) 2000-09-28

Similar Documents

Publication Publication Date Title
PE20001557A1 (es) Nueva cepa lactobacillus que previene diarrea causada por bacterias patogenas
JP2002537865A5 (https=)
AU668397B2 (en) Antigastritis agent
Liong Probiotics: a critical review of their potential role as antihypertensives, immune modulators, hypocholesterolemics, and perimenopausal treatments
CA2380849A1 (en) New bifidobacteria preventing diarrhea caused by pathogenic bacteria
PE20001540A1 (es) Nuevas cepas de bacterias de acido lactico capaces de prevenir la diarrea
RU2001127527A (ru) Новые штаммы lactobacillus, способные предотвращать диарею, вызванную патогенными бактериями и ротавирусами
RU2001127528A (ru) Штаммы lactobacillus, предотвращающие диарею, вызываемую патогенными бактериями
JP2012526748A (ja) 短時間高温処理によって抗炎症性プロファイルを有する微生物調製物が生じる
RU2001127529A (ru) Штаммы молочно-кислых бактерий, способные предотвращать диарею
RU2003112013A (ru) Молочно-кислые бактерии, снижающие склонность к проявлению аллергических реакций
AU779789B2 (en) Lactobacillus strains capable of preventing diarrhoea caused by pathogenic bacteria and rotaviruses
PE20040419A1 (es) Un producto lacteo y un proceso para su fabricacion
CA2378426C (en) Bifidobacteria capable of preventing diarrhea
KR960034401A (ko) 프로바이오틱에 적합한 비피더스균 및 그의 분말 비피더스균 제제
GEU20061256Y (en) Yoghurt
MXPA01008976A (en) Lactobacillus strains preventing diarrhoea pathogenic bacteria
PA8434001A1 (es) Producto de leche fermentada por el cultivo en simbiosis de cepas de lactobacillus casei crl atcc 55544 y lactobacillus acidophillus crl 730 atcc 55543.
CZ20484U1 (cs) Tekutý podpůrný prostředek k získání imunity
CZ21912U1 (cs) Lyofilizovaná sójová kultura
HN1996000026A (es) Producto de leche fermentada por el cultivo en simbiosis de cepas de lactobacillus casei crl 431 atcc 55544 y lactoba- cillus acidophilus crl 730 atcc 55543.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed